These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
464 related items for PubMed ID: 16950207
1. Synergistic induction of apoptosis by sulindac and arsenic trioxide in human lung cancer A549 cells via reactive oxygen species-dependent down-regulation of survivin. Jin HO, Yoon SI, Seo SK, Lee HC, Woo SH, Yoo DH, Lee SJ, Choe TB, An S, Kwon TJ, Kim JI, Park MJ, Hong SI, Park IC, Rhee CH. Biochem Pharmacol; 2006 Nov 15; 72(10):1228-36. PubMed ID: 16950207 [Abstract] [Full Text] [Related]
2. A combination of sulindac and arsenic trioxide synergistically induces apoptosis in human lung cancer H1299 cells via c-Jun NH2-terminal kinase-dependent Bcl-xL phosphorylation. Jin HO, Seo SK, Woo SH, Lee HC, Kim ES, Yoo DH, Lee SJ, An S, Choe TB, Kim JI, Hong SI, Rhee CH, Park IC. Lung Cancer; 2008 Sep 15; 61(3):317-27. PubMed ID: 18281123 [Abstract] [Full Text] [Related]
3. Combined effects of sulindac and suberoylanilide hydroxamic acid on apoptosis induction in human lung cancer cells. Seo SK, Jin HO, Lee HC, Woo SH, Kim ES, Yoo DH, Lee SJ, An S, Rhee CH, Hong SI, Choe TB, Park IC. Mol Pharmacol; 2008 Mar 15; 73(3):1005-12. PubMed ID: 18156316 [Abstract] [Full Text] [Related]
4. Sulindac-derived reactive oxygen species induce apoptosis of human multiple myeloma cells via p38 mitogen activated protein kinase-induced mitochondrial dysfunction. Seo SK, Lee HC, Woo SH, Jin HO, Yoo DH, Lee SJ, An S, Choe TB, Park MJ, Hong SI, Park IC, Rhee CH. Apoptosis; 2007 Jan 15; 12(1):195-209. PubMed ID: 17136320 [Abstract] [Full Text] [Related]
5. A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells. Wang W, Adachi M, Zhang R, Zhou J, Zhu D. Pancreas; 2009 May 15; 38(4):e114-23. PubMed ID: 19342982 [Abstract] [Full Text] [Related]
6. Arsenic trioxide inhibits the growth of Calu-6 cells via inducing a G2 arrest of the cell cycle and apoptosis accompanied with the depletion of GSH. Han YH, Kim SZ, Kim SH, Park WH. Cancer Lett; 2008 Oct 18; 270(1):40-55. PubMed ID: 18539383 [Abstract] [Full Text] [Related]
7. Mitogen-activated protein kinases mediate arsenic-induced down-regulation of survivin in human lung adenocarcinoma cells. Cheng Y, Chang LW, Tsou TC. Arch Toxicol; 2006 Jun 18; 80(6):310-8. PubMed ID: 16328441 [Abstract] [Full Text] [Related]
8. Curcumin stimulates reactive oxygen species production and potentiates apoptosis induction by the antitumor drugs arsenic trioxide and lonidamine in human myeloid leukemia cell lines. Sánchez Y, Simón GP, Calviño E, de Blas E, Aller P. J Pharmacol Exp Ther; 2010 Oct 18; 335(1):114-23. PubMed ID: 20605902 [Abstract] [Full Text] [Related]
9. ASK1 is activated by arsenic trioxide in leukemic cells through accumulation of reactive oxygen species and may play a negative role in induction of apoptosis. Yan W, Arai A, Aoki M, Ichijo H, Miura O. Biochem Biophys Res Commun; 2007 Apr 20; 355(4):1038-44. PubMed ID: 17331470 [Abstract] [Full Text] [Related]
10. The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells. Liu X, Yue P, Chen S, Hu L, Lonial S, Khuri FR, Sun SY. Cancer Res; 2007 May 15; 67(10):4981-8. PubMed ID: 17510429 [Abstract] [Full Text] [Related]
11. Increased apoptotic efficacy of lonidamine plus arsenic trioxide combination in human leukemia cells. Reactive oxygen species generation and defensive protein kinase (MEK/ERK, Akt/mTOR) modulation. Calviño E, Estañ MC, Simón GP, Sancho P, Boyano-Adánez Mdel C, de Blas E, Bréard J, Aller P. Biochem Pharmacol; 2011 Dec 01; 82(11):1619-29. PubMed ID: 21889928 [Abstract] [Full Text] [Related]
12. Interferon-gamma-induced sensitization of colon carcinomas to ZD9331 targets caspases, downstream of Fas, independent of mitochondrial signaling and the inhibitor of apoptosis survivin. Geller J, Petak I, Szucs KS, Nagy K, Tillman DM, Houghton JA. Clin Cancer Res; 2003 Dec 15; 9(17):6504-15. PubMed ID: 14695155 [Abstract] [Full Text] [Related]
13. The effect of MAPK inhibitors on arsenic trioxide-treated Calu-6 lung cells in relation to cell death, ROS and GSH levels. Han YH, Moon HJ, You BR, Kim SZ, Kim SH, Park WH. Anticancer Res; 2009 Oct 15; 29(10):3837-44. PubMed ID: 19846917 [Abstract] [Full Text] [Related]
14. Quercetin decreases intracellular GSH content and potentiates the apoptotic action of the antileukemic drug arsenic trioxide in human leukemia cell lines. Ramos AM, Aller P. Biochem Pharmacol; 2008 May 15; 75(10):1912-23. PubMed ID: 18359480 [Abstract] [Full Text] [Related]
15. Survivin is a downstream target and effector of sulindac-sensitive oncogenic Stat3 signalling in head and neck cancer. Scheper MA, Nikitakis NG, Sauk JJ. Int J Oral Maxillofac Surg; 2007 Jul 15; 36(7):632-9. PubMed ID: 17566705 [Abstract] [Full Text] [Related]
16. Arsenic trioxide-induced apoptosis and its enhancement by buthionine sulfoximine in hepatocellular carcinoma cell lines. Kito M, Akao Y, Ohishi N, Yagi K, Nozawa Y. Biochem Biophys Res Commun; 2002 Mar 08; 291(4):861-7. PubMed ID: 11866444 [Abstract] [Full Text] [Related]
17. Modulation of arsenic trioxide-induced apoptosis by genistein and functionally related agents in U937 human leukaemia cells. Regulation by ROS and mitogen-activated protein kinases. Sánchez Y, Calle C, de Blas E, Aller P. Chem Biol Interact; 2009 Nov 10; 182(1):37-44. PubMed ID: 19720055 [Abstract] [Full Text] [Related]
18. Arsenic trioxide induced the apoptosis of laryngeal cancer via down-regulation of survivin mRNA. Cheng B, Yang X, Han Z, An L, Liu S. Auris Nasus Larynx; 2008 Mar 10; 35(1):95-101. PubMed ID: 17869043 [Abstract] [Full Text] [Related]
19. Anthraquinones sensitize tumor cells to arsenic cytotoxicity in vitro and in vivo via reactive oxygen species-mediated dual regulation of apoptosis. Yang J, Li H, Chen YY, Wang XJ, Shi GY, Hu QS, Kang XL, Lu Y, Tang XM, Guo QS, Yi J. Free Radic Biol Med; 2004 Dec 15; 37(12):2027-41. PubMed ID: 15544921 [Abstract] [Full Text] [Related]
20. Effects of arsenic trioxide on cell death, reactive oxygen species and glutathione levels in different cell types. Han YH, Moon HJ, You BR, Kim SZ, Kim SH, Park WH. Int J Mol Med; 2010 Jan 15; 25(1):121-8. PubMed ID: 19956910 [Abstract] [Full Text] [Related] Page: [Next] [New Search]